Zobrazeno 1 - 10
of 64
pro vyhledávání: '"Tadej Pajič"'
Autor:
Saša Anžej Doma, Nika Kraljić, Aleša Kristan, Nataša Debeljak, Aleš Maver, Tadej Pajič, Irena Preložnik Zupan
Publikováno v:
Frontiers in Medicine, Vol 11 (2024)
BackgroundCongenital erythrocytosis (CE) is increasingly recognized as the cause of erythrocytosis in patients in whom polycythemia vera and secondary acquired causes have been excluded. The aim of our study was to determine possible genetic backgrou
Externí odkaz:
https://doaj.org/article/c87e5cdebb334e71a89c41aff22e607a
Autor:
Aleša Kristan, Tadej Pajič, Aleš Maver, Tadeja Režen, Tanja Kunej, Rok Količ, Andrej Vuga, Martina Fink, Špela Žula, Helena Podgornik, Saša Anžej Doma, Irena Preložnik Zupan, Damjana Rozman, Nataša Debeljak
Publikováno v:
Frontiers in Genetics, Vol 12 (2021)
An erythrocytosis is present when the red blood cell mass is increased, demonstrated as elevated hemoglobin and hematocrit in the laboratory evaluation. Congenital predispositions for erythrocytosis are rare, with germline variants in several genes i
Externí odkaz:
https://doaj.org/article/e2d1e10e99874627bc2743516f61c758
Autor:
Nataša Debeljak, Julija Lazarevič, Dejan Miskič, Lucija Vermiglio, Anja Kopitar, Anja Solarovič, Matjaž Sever, Martina Fink, Tadej Pajič, Saša Anžej Doma, Miha Moškon, Irena Preložnik Zupan
Publikováno v:
Zdravniški Vestnik, Vol 88, Iss 5-6, Pp 263-275 (2019)
Eritrocitoza je stanje s povečano maso eritrocitov v telesu. Odrazi se s povečanim hematokritom, zvečano koncentracijo hemoglobina in povečanim številom eritrocitov v krvi. Ločimo absolutno in relativno eritrocitozo. Absolutne oblike pa nato de
Externí odkaz:
https://doaj.org/article/88e36c1f4f35471898ebbfd29c4b7659
Autor:
Tanja Belčič Mikič, Bor Vratanar, Tadej Pajič, Saša Anžej Doma, Nataša Debeljak, Irena Preložnik Zupan, Matjaž Sever, Samo Zver
Publikováno v:
Journal of Clinical Medicine, Vol 10, Iss 24, p 5803 (2021)
JAK2, MPL, and CALR mutations define clonal thrombocytosis in about 90% of patients with sustained isolated thrombocytosis. In the remainder of patients (triple-negative patients) diagnosing clonal thrombocytosis is especially difficult due to the di
Externí odkaz:
https://doaj.org/article/080329375f56498794dc84c48e3fc12e
Publikováno v:
International Journal of Molecular Sciences, Vol 22, Iss 7, p 3371 (2021)
CALR mutations are a revolutionary discovery and represent an important hallmark of myeloproliferative neoplasms (MPN), especially essential thrombocythemia and primary myelofibrosis. To date, several CALR mutations were identified, with only framesh
Externí odkaz:
https://doaj.org/article/cb1a9a08fe2f494faff38cf673dbc470
Autor:
Irena Preložnik Zupan, Karla Rener, Helena Podgornik, Matjaž Sever, Martina Fink, Mateja Grat, Tadej Pajič
Publikováno v:
Zdravniški Vestnik, Vol 87, Iss 3-4 (2018)
The paper presents recommendations for the management of patients with chronic myeloid leukaemia. Clinical manifestations, diagnostics, treatment and monitoring of treatment are presented.
Externí odkaz:
https://doaj.org/article/ebdde5e8bde54a498810c6e75d1106cd
Autor:
Majda Benedik Dolničar, Barbara Faganel Kotnik, Lidija Kitanovski, Irena Preložnik Zupan, Saša Anžej Doma, Maruša Debeljak, Tadej Pajič, Janez Jazbec, Petra Dovč, Tanja Tomaževič, Mojca Matičič, Janez Tomažič, Nataša Tul Mandić, Alenka Trampuš Bakija
Publikováno v:
Zdravniški Vestnik, Vol 86, Iss 9-10 (2017)
The document presents recommendations for the comprehensive treatment of patients with haemophilia in Slovenia. It enables health workers at all three levels of health care to become well-acquainted with all the possible aspects of treatment based on
Externí odkaz:
https://doaj.org/article/d081d8c235714ae38135bdea6b4b685f
Publikováno v:
Haematologica, Vol 98, Iss 7 (2013)
Externí odkaz:
https://doaj.org/article/c2764f0ece244644acf086b08ef0ad5f
Publikováno v:
Zdravniški Vestnik, Vol 81, Iss SUPL II (2012)
Background: D816V mutation in the C-KIT gene is present in more than 90 % of patients with systemic mastocytosis (SM) and 2–7 % of patients with acute myeloid leukemia (AML). D816V mutation is caused by the substitution of adenine with thymine at 2
Externí odkaz:
https://doaj.org/article/0b431ca391d6492d99d1a6b926fc5a4c
Autor:
Irena Preložnik Zupan, Tadej Pajič, Marjana Glaser, Tatjana Grmek Zemljič, Mateja Grat, Nataša Fikfak, Irena Bricman, Marija Čeh, Vlasta Petric, Milica Skamagkoulis
Publikováno v:
Zdravniški Vestnik, Vol 81, Iss SUPL II (2012)
Background: Chronic myeloid leukemia (CML) is a malignant myeloproliferative disorder of hematopoietic stem cells. It is the first malignancy with a known specific chromosomal abnormality, the Philadelphia (Ph) chromosome t(9;22) (q34;q11), which has
Externí odkaz:
https://doaj.org/article/f93cd3e29ca74c11a752947b092a3909